血液透析患者頑固性皮膚潰瘍伴下肢動脈重度閉塞兩例_West China Medical Journal

Authors：

任智敏 ^1,2 , 李娟 ¹ , 陳林 ¹ , 黃斌 ³ ,  周莉 ¹ , 付平 ¹

1. ;
2. ;
3. ;

Corresponding?author：

周莉, Email: 446125447@qq.com

Keywords：

血液透析; 鈣化防御; 微球囊; 下肢動脈閉塞

DOI：

10.7507/1002-0179.202105268

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 任智敏, 李娟, 陳林, 黃斌, 周莉, 付平. 血液透析患者頑固性皮膚潰瘍伴下肢動脈重度閉塞兩例. West China Medical Journal, 2021, 36(7): 995-997. doi: 10.7507/1002-0179.202105268 Copy

1.	Ruderman I, Toussaint ND, Hawley CM, et al. The Australian Calciphylaxis Registry: reporting clinical features and outcomes of patients with calciphylaxis. Nephrol Dial Transplant, 2021, 36(4): 649-656.
2.	Chinnadurai R, Huckle A, Hegarty J, et al. Calciphylaxis in end-stage kidney disease: outcome data from the United Kingdom Calciphylaxis Study. J Nephrol, 2021: 6.
3.	劉茁, 紀明開, 陳穎, 等. 閉塞性動脈硬化癥誤診為硬皮病 1 例. 中國皮膚性病學雜志, 2005, 19(7): 439-440.
4.	Udomkarnjananun S, Kongnatthasate K, Praditpornsilpa K, et al. Treatment of calciphylaxis in CKD: a systematic review and meta-analysis. Kidney Int Rep, 2018, 4(2): 231-244.
5.	賴瑋婧, 江玉波, 王少清. 下肢鈣化防御 1 例并文獻復習. 中國皮膚性病學雜志, 2019, 33(7): 811-813.
6.	Hayden MR, Goldsmith DJ. Sodium thiosulfate: new hope for the treatment of calciphylaxis. Semin Dial, 2010, 23(3): 258-262.
7.	Mccarthy JT, El-Azhary RA, Patzelt MT, et al. Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis. Mayo Clin Proc, 2016, 91(10): 1384-1394.
8.	Liu Y, Zhang X, Xie X, et al. Risk factors for calciphylaxis in Chinese hemodialysis patients: a matched case-control study. Ren Fail, 2021, 43(1): 406-416.
9.	Gabel CK, Nguyen ED, Chakrala T, et al. Assessment of outcomes of calciphylaxis. J Am Acad Dermatol, 2020, 29: S0190-9622(20)32880-2.
10.	Matsumoto T, Tomita K, Suda S, et al. Microballoon-related interventions in various endovascular treatments of body trunk lesions. Minim Invasive Ther Allied Technol, 2018, 27(1): 2-10.
11.	吳慶云, 祝艷華. 應用“TIME”原則指導深度壓瘡創面的修復. 創傷外科雜志, 2017, 19(1): 71-72.

1. Ruderman I, Toussaint ND, Hawley CM, et al. The Australian Calciphylaxis Registry: reporting clinical features and outcomes of patients with calciphylaxis. Nephrol Dial Transplant, 2021, 36(4): 649-656.
2. Chinnadurai R, Huckle A, Hegarty J, et al. Calciphylaxis in end-stage kidney disease: outcome data from the United Kingdom Calciphylaxis Study. J Nephrol, 2021: 6.
3. 劉茁, 紀明開, 陳穎, 等. 閉塞性動脈硬化癥誤診為硬皮病 1 例. 中國皮膚性病學雜志, 2005, 19(7): 439-440.
4. Udomkarnjananun S, Kongnatthasate K, Praditpornsilpa K, et al. Treatment of calciphylaxis in CKD: a systematic review and meta-analysis. Kidney Int Rep, 2018, 4(2): 231-244.
5. 賴瑋婧, 江玉波, 王少清. 下肢鈣化防御 1 例并文獻復習. 中國皮膚性病學雜志, 2019, 33(7): 811-813.
6. Hayden MR, Goldsmith DJ. Sodium thiosulfate: new hope for the treatment of calciphylaxis. Semin Dial, 2010, 23(3): 258-262.
7. Mccarthy JT, El-Azhary RA, Patzelt MT, et al. Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis. Mayo Clin Proc, 2016, 91(10): 1384-1394.
8. Liu Y, Zhang X, Xie X, et al. Risk factors for calciphylaxis in Chinese hemodialysis patients: a matched case-control study. Ren Fail, 2021, 43(1): 406-416.
9. Gabel CK, Nguyen ED, Chakrala T, et al. Assessment of outcomes of calciphylaxis. J Am Acad Dermatol, 2020, 29: S0190-9622(20)32880-2.
10. Matsumoto T, Tomita K, Suda S, et al. Microballoon-related interventions in various endovascular treatments of body trunk lesions. Minim Invasive Ther Allied Technol, 2018, 27(1): 2-10.
11. 吳慶云, 祝艷華. 應用“TIME”原則指導深度壓瘡創面的修復. 創傷外科雜志, 2017, 19(1): 71-72.

Previous Article
Periodontitis and benign prostatic hyperplasia and prostatitis
Next Article
數字減影血管造影引導下上腔靜脈直接穿刺隧道式帶滌綸套導管置入一例

West China Medical Journal

血液透析患者頑固性皮膚潰瘍伴下肢動脈重度閉塞兩例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content